Estimating medical practice expenses from administering adult influenza vaccinations

Potential business losses incurred vaccinating adults against influenza have not been defined because of a lack of estimates for medical practice costs incurred delivering vaccines. We collected data on vaccination labor time and other associated expenses. We modeled estimates of per-vaccination med...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2005-01, Vol.23 (7), p.915-923
Main Authors: Coleman, Margaret S., Fontanesi, John, Meltzer, Martin I., Shefer, Abigail, Fishbein, Daniel B., Bennett, Nancy M., Stryker, David
Format: Article
Language:English
Subjects:
Accounting - methods
Adult
Adult influenza vaccination
Applied microbiology
Biological and medical sciences
Costs and Cost Analysis
Economic evaluation
Economics, Medical - trends
Fees and Charges
Fundamental and applied biological sciences. Psychology
Hospitals
Humans
Immunization
Influenza Vaccines - administration & dosage
Influenza Vaccines - economics
Medicare
Microbiology
Physicians
Practice Management, Medical - economics
Sensitivity and Specificity
Vaccination - economics
Vaccination costs
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Potential business losses incurred vaccinating adults against influenza have not been defined because of a lack of estimates for medical practice costs incurred delivering vaccines. We collected data on vaccination labor time and other associated expenses. We modeled estimates of per-vaccination medical practice business costs associated with delivering adult influenza vaccine in different sized practices. Per-shot costs ranged from US$ 13.87 to US$ 46.27 (2001 dollars). When compared with average Medicare payments of US$ 11.71, per-shot losses ranged from US$ 2.16 to US$ 34.56. More research is needed to determine less expensive delivery settings and/or whether third-party payers need to make higher payments for adult vaccinations.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2004.07.028